Report Publication Announcement • Jun 8, 2015
Report Publication Announcement
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 8 June 2015 07:00
Cytos Biotechnology AG invites to the Annual General Meeting
Cytos Biotechnology AG / Key word(s): AGM/EGM
2015-06-08 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.
Cytos Biotechnology Ltd. invites to the Annual General Meeting
Schlieren (Zurich), Switzerland, June 8, 2015 – Cytos Biotechnology Ltd (“Cytos”) today announced that the Annual General Meeting 2015 will take place on Monday, June 29, 2015 at 11 a.m. at Cytos’ offices in Schlieren/Zurich (Switzerland).
The formal invitation to the meeting will be sent out within the next few days and can also be downloaded from the following website:
http://www.cytos.com/uploads/2015/AGM2015.pdf
For further information, please contact:
Cytos Biotechnology Ltd
Harry Welten, MBA
Chief Financial Officer
Tel: +41 44 733 46 46
About Cytos Biotechnology Ltd
Cytos is a public biopharmaceutical company located in Schlieren (Zurich), Switzerland. The Company is listed according to the Main Standard on the SIX Swiss Exchange Ltd under the symbol CYTN.
Forward Looking Statements
This media release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. You are urged to consider statements that include the words “will” or “expect” or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include scientific, business, economic and financial factors, Against the background of these uncertainties, readers should not rely on forward-looking statements. The Company assumes no responsibility for updating forward-looking statements or adapting them to future events or developments.
End of ad hoc announcement
+++++
Additional features:
Document: http://n.equitystory.com/c/fncls.ssp?u=UXLSRJPYGR
Document title: Cytos_AGM2015
2015-06-08 News transmitted by EQS Schweiz AG. www.eqs.com – news archive: http://switzerland.eqs.com/de/News
The issuer is responsible for the contents of the release.
| Language: | English |
| Company: | Cytos Biotechnology AG |
| Wagistr. 25 | |
| 8952 Schlieren | |
| Switzerland | |
| Phone: | +41 44 733 4747 |
| Fax: | +41 44 733 4740 |
| E-mail: | [email protected] |
| Internet: | www.cytos.com |
| ISIN: | CH0011025217, CH0029060735 |
| Valor: | – |
| Listed: | Regulated Unofficial Market in Berlin, Munich, Stuttgart; Open Market in Frankfurt ; SIX |
| End of News | EQS Group News-Service |
| - - - |
| 365761 2015-06-08 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.